Identification, Susceptibility & Resistance

Slides:



Advertisements
Similar presentations
OPPORTUNISTIC MYCOSES
Advertisements

Is azole resistance increasing amongst Aspergillus species?
OPPORTUNISTIC MYCOSES
OPPORTUNISTIC FUNGAL INFECTIONS
Trends in fungal diseases Dr David W. Denning FRCP FRCPath Scientific Advisor to the Fungal Research Trust Clinician, Wythenshawe Hospital Head, Antifungal.
SEROLOGY OF FUNGAL INFECTIONS
Fungal Infection in the ICU
Respiratory Fungal Infections Dr. Ahmed Al-Barrag Asst. Professor of Medical Mycology School of Medicine and the University Hospitals King Saud University.
Initial Antifungal Therapy for Critical Ill Patients When and Which ? 林口長庚 胸腔內科 林鴻銓 Lin, Horng-Chyuan Division of Pulmonary Infectious & Immunological.
Identification of Unusual Clinical Yeast Isolates: A 2 Year Review of Internal Transcribed Spacer (ITS) Region Sequence Analysis E. Susan Slechta 1,Sheri.
Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.
Antifungal management in the haematology patient
Evaluation of the FUNGIFAST ® AFG yeast antifungal susceptibility test : comparison with EUCAST and the E-Test method INTERNAL STUDY - (ELITECH GROUP -
Lecture Title: Fungal Infections of Central Nervous System
Medical Mycology.
Mycology – Yeast Student Lab Division of Medical Technology Carol Larson MSEd, MT(ASCP)
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.
Microbiology Lab 10 Basic Mycology.
Mycology.
Respiratory Fungal Infections
Respiratory Fungal Infections
Lecturer name: Dr. Ahmed M. Al-Barrag Lecture Date:
Opportunistic Fungal Infections
FUNGAL INFECTIONS and ANTIFUNGAL AGENTS
Treatment of Aspergillosis John R. Perfect Duke University Medical Center.
Fungal infections 400 out of 75,000 Primary infections Opportunistic infections Myco-toxins Allergy.
AbstractAbstract IntroductionIntroduction MethodsMethods ResultsResults Candida albicans accounted for 45.2%, Candida tropicalis 22.3%, Candida glabrata.
NCCLS (1997) Approved standard M27-A. Rex JH et al. Clin Infect Dis (1997) 24: Pfaller M. A., et al. Diagn Microbiol Infect Dis (1999); 35:19-25.
Which drugs?. Mode of action of antifungals ergosterol polyenes e.g. amphotericin B polyenes azoles e.g. fluconazole azoles nucleosides e.g. 5-flucytosine.
CANDIDIASIS Endocrine block March 2014 Dr. Ahmed Al-Barrag Asst. Professor of Medical Mycology School of Medicine and the University Hospitals King Saud.
A rare case of Candida parapsilosis osteomyelitis in a diabetic woman with basal cell carcinoma BACKGROUND Candida parapsilosis is the most common non-albicans.
Selection of an optimal antifungal for treatment of invasive aspergillosis: susceptibility/resistance, adverse reactions, drug interactions John Bennett,
EVIDENCE Clinical Management of Invasive Fungal Infections: An Evidence-Based Approach.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2011 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
CANDIDA & CRYTOCOCCUS Prepared by: Miss Norzawani Jaffar Bsc (Hons) Biomedical Sciences, UKM Lecture 15.
neoformans causes cryptococcal meningitis. C neoformans is an oval, budding yeast surrounded by a wide polysaccharide.
Opportunistic Pathogens –Aspergillus species. Aspergillosis is an infection caused by Aspergillus, a common mold that lives indoors and outdoors. Most.
OPPORTUNISTIC MYCOSES
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012
Respiratory Fungal Infections-II Dr. Ahmed Al-Barrag Asst. Professor of Medical Mycology School of Medicine and the University Hospitals King Saud University.
Candidiasis (candidosis) old name Moniliasis General: This is any infection caused by any species of the yeast fungus Candida or few other yeasts It ’
I didn’t repeat wt we took at practical 1 and 2 ^^
Diversity of Fungi and Fungal Infections
Dr. A.Aziz Djamal MSc.DTM&H.SpMK(K ). 1. Cosmopolitant : Aspergillus, Candida and Cryptococcosis. 2. Exotic type : In a specific area Penicillium marneffei.
Hospital-acquired Invasive Aspergillosis: How Big is the Problem?
Fungi of superficial keratinized infection
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Aspergillus  Aspergillus is a filamentous, hyaline mold.  It can grow on dead leaves, stored grain, and other decaying vegetation.  Large numbers of.
ASPERGILLOSIS Prof. Khaled H. Abu-Elteen ASPERGILLOSIS Aspergilli produce a wide variety of diseases. Like the zygomycetes, they are ubiquitous in nature.
Opportunistic mycosis Dr.Huda Ibrahim
RESPIRATORY FUNGAL INFECTION. YEASTMOULD FUNGIDIMORPHIC FUNGI OpportunisticPrimary Infectious Candidiasis (Candida and other yeast) Aspergillosis (Aspergillus.
Respiratory Fungal Infections
Dr C Sriruttan Clinical Microbiology & Infectious Disease /11/20161 Principles & Approach.
1. Candida 의 항진균제 감수성과 항진균제 간의 교차내성 2. Disseminated candidiasis 의 치료 약제 선택 3. Refractory case 에서의 치료 약제 선택.
Candidiasis A primary or secondary mycotic infection caused by members of the genus Candida. The clinical manifestations may be acute, subacute or chronic.
Opportunistic Mycoses Batch 17 April 17, 2012 Dr S Gokul Shankar
Opportunistic Mycoses Infections due to fungi of low virulence in patients who are immunologically compromised.
PHARMACEUTICAL MICROBIOLOGY -I PHT 226 Dr. Rasheeda Hamid Abdalla Assistant Professor hotmail.com.
Opportunistic mycosis Dr.Huda Ibrahim
Lecture Title: Fungal Infections of Central Nervous System
Candidiasis Endocrine block.
Candidiasis Endocrine block.
Comparative Methods of Speciation of Candida Isolated from Patients with Vulvovaginitis in Ekpoma and Environs, Nigeria. N. J. Inyang1, I. B. Enweani2,
Brielle Haas RISE Spring 2015 Dr. Gullo
Diversity of Fungi and Fungal Infections
Low rates of voriconazole resistance and absence of CYP51A mutations among A. fumgiatus recovered from lung transplant recipients receiving prophylaxis.
Efficacy of Chromogenic Candida Agar for isolation and presumptive identification of pathogenic yeast species  E. Ghelardi, G. Pichierri, B. Castagna,
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2018
Lecturer name: Dr. Ahmed M. Albarrag
Presentation transcript:

Identification, Susceptibility & Resistance Dr Caroline B. Moore Mycology Reference Centre University Hospital of South Manchester The University of Manchester

Yeasts

Why bother with identification & susceptibility testing? Significant number of invasive fungal infections Increase in ‘at-risk’ patient population

Why bother with identification & susceptibility testing? Significant number of invasive fungal infections Increase in ‘at-risk’ patient population Increase in non-C. albicans species Increase in ‘rarer’ species The literature provides many examples of an increase in species other than Candida albicans.

Proportion of nosocomial Candida infections caused by different species in a teaching hospital Berrouane et al. J Clin Micro 1999; 37:531

Why bother with identification & susceptibility testing? Significant number of invasive fungal infections Increase in ‘at-risk’ patient population Increase in non-C. albicans species Increase in ‘rarer’ species Increase in drug resistance

Increasing fluconazole resistance in Intensive Care Unit Moore et al. ECMM 1998

Why bother with identification & susceptibility testing? Significant number of invasive fungal infections Increase in ‘at-risk’ patient population Increase in non-C. albicans species Increase in ‘rarer’ species Increase in drug resistance More drug choices available Informed therapeutic choice

How do we identify yeasts? Culture morphology Chromagar

How do we identify yeasts? Germ tube test Microscopic morphology Terminal chlamydospores Arthrospores Other tests

How do we identify yeasts? Traditional methods Wickerham tests Auxacolor Commercial kits numerous! Vitek-2 API ID 32C Molecular methods

MICs He uses statistics like a drunken man uses lamp-posts ... For support rather than illumination

Do we have a good test of susceptibility for yeasts? CLSI (NCCLS) M27-A3 method USA standard EUCAST Document E-Def 7.1 method European standard Extensive clinical correlation work

Do we have a good test of susceptibility for yeasts? Disc diffusion no MIC obtained screening method E-test strips MIC value obtained problematic endpoints

Some are more equal than others! Do we have a good test of susceptibility for yeasts? An array of commercial formats Vitek-2 YeastOne Fungitest Others… Some are more equal than others! Molecular methods

Candida albicans Most common cause of candidosis (50-70%) Can cause a wide range of diseases May cause vaginal and oral/oesophageal thrush Produces germ tubes Attributable mortality (18-25%) differences in patient age and underlying illness

Candida albicans - + ++ + ++ ++ ++ Azole susceptibility can depend on HIV status FLU ITR VOR POS AMB 5FC CASP C.albicans ++ ++ ++ ++ ++ ++ ++ C.albicans - FLU-resistant - + ++ + ++ ++ ++ Rates of resistance seen in our laboratory 1992-2006 flucytosine 6% fluconazole 1.2% 5% of C. albicans with reduced susceptibility

Candida parapsilosis complex Candida parapsilosis, Candida orthopsilosis, Candida metapsilosis 2nd most common species in blood, related to catheters and glucose solutions including TPN Often seen in neonates Generally do not cause thrush Less pathogenic than C. albicans

Candida parapsilosis complex FLU ITR VOR POS AMB 5FC CASP C.parapsilosis ++ ++ ++ ++ ++ + - Rates of resistance seen in our laboratory 1992-2006 fluconazole 0.4%

Candida glabrata 3rd or 4th most common species in blood Increasing in many institutions Common cause of thrush, particularly vaginal Generally thought as unable to produce pseudohyphae in vitro Evidence of ability to grow as filamentous organism

Rates of resistance seen in our laboratory 1992-2006 Candida glabrata Usually reduced susceptibility to fluconazole Responds poorly to amphotericin B FLU ITR VOR POS AMB 5FC CASP C.glabrata + + + + + ++ ++ Rates of resistance seen in our laboratory 1992-2006 fluconazole 53%

Candida tropicalis Usually 4th most common species in blood, much commoner in some institutions Generally does not cause thrush More invasive than other Candida species High attributable mortality (33-50%) High frequency (~80-100%) of infection if coloniser during neutropenia

Rates of resistance seen in our laboratory 1992-2006 Candida tropicalis Usually fluconazole susceptible, but may develop resistance quickly FLU ITR VOR POS AMB 5FC CASP C.tropicalis + ++ ++ ++ ++ ++ ++ Rates of resistance seen in our laboratory 1992-2006 flucytosine 20% fluconazole 46%

Candida krusei 5th most common species in blood Does not cause thrush, except in late-stage AIDS High mortality in leukaemic patients

Candida krusei May be a breakthrough species Always fluconazole resistant and amphotericin intermediate FLU ITR VOR POS AMB 5FC CASP C.krusei - + + + + + ++

Cryptococcus neoformans Neurotropic fungus Most common predisposing factor is AIDS Also organ transplant recipients or cancer patients receiving chemotherapeutics Produces a polysaccharide capsule - major virulence factor

Cryptococcus neoformans Combination therapy generally used FLU ITR VOR POS AMB 5FC CASP Crypto. neoformans + + ++ ++ ++ + - Cryptococcus would generally be susceptible to some degree to most of the drugs – the exception is caspofungin which is intrinsically resistant. The most commonly used agents for treatment of cryptococcal infections are amphotericin B and flucytosine in combination.

High degree of mortality Rhodotorula mucilaginosa Image Courtesy of Carsten Kettner Saccharomyces species Malassezia species High degree of mortality

Can be intrinsically resistant to some antifungal drugs Species of…. Trichosporon Geotrichum Blastoschizomyces Can be intrinsically resistant to some antifungal drugs

Moulds - the Aspergilli

Increasing incidence of invasive aspergillosis in hematopoietic stem cell transplant recipients Marr et al. Clin Infect Dis 2002; 34:909

What tests do we have to identify moulds? morphology microscopy additional tests molecular methods Experience!

Can be a secondary pathogen in cases of carcinoma or TB Aspergillus Wide spectrum of disease – dependent on immune status Allergic bronchopulmonary aspergillosis Pulmonary aspergilloma Invasive aspergillosis Can be a secondary pathogen in cases of carcinoma or TB

Aspergillus fumigatus complex most common cause of aspergillosis ~90% of cases

Aspergillus niger complex Common cause of ear infections

Aspergillus terreus complex Cause of superficial, eye, ear and systemic infections

Aspergillus flavus complex Cause of pulmonary and sinus infections

In vitro susceptibility of filamentous fungi ITR VOR POS AMB 5FC CASP FLU Asp. fumigatus ++ ++ ++ ++ +/- ++ - Asp. niger ++ ++ ++ ++ - ++ - Asp. terreus ++ ++ ++ - - ++ - Asp. flavus ++ ++ ++ ++ - ++ -

Azole resistance in A. fumigatus complex Itraconazole recent literature 0 - 5% 7% RMLM 1992 – 2007 (n = 519) significant increase in resistance since 2004 – now 13% Itraconazole resistant isolates 58% cross-resistant to voriconazole 66% cross-resistant to posaconazole Data from Dr Susan Howard

Azole cross resistance of Asp. fumigatus complex MIC mg/L Mosquera & Denning. Antimicrob Agents Chemother 2002; 46:556

Other Aspergilli Klich MA. Identification of common Aspergillus species (2002). CBS.

Non-Aspergillus moulds

Increasing frequency of non-Aspergillus mould infections in hematopoietic stem cell transplant recipients Marr et al. Clin Infect Dis 2002; 34:909

Range of disease from cutaneous through to disseminated infection Fusarium spp. Range of disease from cutaneous through to disseminated infection

Scedosporium spp. Can cause subcutaneous infections but dissemination may occur in immunocompromised host

Cunninghamella Rhizomucor Rhizopus Absidia Mucor etc… Mucorales Cunninghamella Rhizomucor Rhizopus Absidia Mucor etc…

In vitro susceptibility of filamentous fungi ITR VOR POS AMB 5FC CASP FLU Asp. fumigatus ++ ++ ++ ++ +/- ++ - Asp. niger ++ ++ ++ ++ - ++ - Asp. terreus ++ ++ ++ - - ++ - Asp. flavus ++ ++ ++ ++ - ++ - Fusarium - + +/- +/- - - - Scedosporium +/- + +/- - - +/- - Mucorales - - + + - - -

Others… Alternaria Plus many more… Acremonium Paecilomyces Penicillium Wangiella Acremonium Penicillium Cladophialophora Phialophora Alternaria Plus many more…

Take time to ‘know’ the fungus in your hospital…. Better the devil….